( 02616.hk)
市盈率-15.58市净率5.01市销率5.02股息率0.00%上市时间2019-02-26股价1.96港币 (-1.51% , 329.27万港币) 市值25.17亿港币总股本12.84亿上市至今年化投资收益率-27.91%
所属三级行业生物技术 (恒生) 市盈率-49.59市净率2.75市销率5.16股息率0.63%
备注 (1): 双击编辑备注
发表讨论

基石药业-B(02616) - 历史董事名单

# 姓名职衔职位委任日期辞任日期
1楊建新Executive DirectorCEO2022-08-25--
2HITCHNER III Walton KennethNon Executive Director2021-12-10--
3胡正國Non Executive Director2021-07-09--
4林向紅Non Executive Director2020-11-30--
5曹彥凌Non Executive Director2019-05-152023-01-18
6CHEW Herbert PaulIndependent Non Executive Director2019-02-14--
7孫洪斌Independent Non Executive Director2019-02-14--
8胡定旭Independent Non Executive Director2019-02-14--
9陳連勇Non Executive Director2018-08-142021-07-09
10張國斌Non Executive Director2018-05-082020-11-30
11童小幪Non Executive Director2018-02-282019-05-15
12JIANG Ning Jun FrankExecutive Director2016-11-032022-08-25
13趙群Non Executive Director2016-04-012021-12-10
14李偉Non Executive DirectorChairman2015-12-02--